[Federal Register Volume 62, Number 112 (Wednesday, June 11, 1997)]
[Notices]
[Page 31852]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15273]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

AGENCY: U.S. Nuclear Regulatory Commission (NRC).

ACTION: Notice of the OMB review of information collection and 
solicitation of public comment.

-----------------------------------------------------------------------

SUMMARY: The NRC has recently submitted to OMB for review the following 
proposal for the collection of information under the provisions of the 
Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35).
    1. Type of submission, new, revision, or extension: Revision.
    2. The title of the information collection: Proposed rule, 10 CFR 
Parts 30 and 32--Exempt Distribution of a Radioactive Drug Containing 
One Microcurie of Carbon-14 Urea.
    3. The form number if applicable: NRC Form 313.
    4. How often the collection is required: On occasion.
    5. Who will be required or asked to report: Manufacturers and 
distributors of the radioactive drug containing Carbon-14 urea.
    6. An estimate of the number of responses: 3.
    7. The estimated number of annual respondents: 3.
    8. An estimate of the total number of hours needed annually to 
complete the requirement or request: 54 hours initially; thereafter 48 
hours annually--16 hours for each of 3 respondents (48 hours per year 
reporting burden and a one-time 6-hour recordkeeping burden, 2 hours 
for each of 3 respondents)
    9. An indication of whether Section 3507(d). Pub. L. 104-13 
applies: Applicable.
    10. Abstract: In response to a petition for rulemaking submitted by 
Tri-Med Specialties, Inc., the NRC is proposing to amend its 
regulations to allow NRC licensees to distribute a radioactive drug 
containing one microcurie of carbon-14 urea to any person for ``in 
vivo'' diagnostic use. The adoption of this amendment would make the 
drug more widely available, thus reducing costs to patients.
    Submit, by July 11, 1997, comments that address the following 
questions:
    1. Is the proposed collection of information necessary for the NRC 
to properly perform its functions? Does the information have practical 
utility?
    2. Is the burden estimate accurate?
    3. Is there a way to enhance the quality, utility, and clarity of 
the information to be collected?
    4. How can the burden of the information collection be minimized, 
including the use of automated collection techniques or other forms of 
information technology?
    A copy of the submittal may be viewed free of charge at the NRC 
Public Document Room, 2120 L Street NW, (Lower Level), Washington, DC. 
The proposed rule indicated in ``The title of the information 
collection'' is or has been published in the Federal Register within 
several days of the publication date of this Federal Register Notice. 
Instructions for accessing the electronic OMB clearance package for the 
rulemaking have been appended to the electronic rulemaking. Members of 
the public may access the electronic OMB clearance package by following 
the directions for electronic access provided in the preamble to the 
titled rulemaking.
    Comments and questions should be directed to the OMB reviewer by 
July 11, 1997: Edward Michlovich, Office of Information and Regulatory 
Affairs (3150-0001), NEOB-10202, Office of Management and Budget, 
Washington DC 20503.
    Comments can also be submitted by telephone at (202) 395-3084.
    The NRC Clearance Officer is Brenda Jo. Shelton, (301) 415-7233.

    Dated at Rockville, Maryland, this 5th day of June, 1997.

    For the Nuclear Regulatory Commission.
Arnold E. Levin,
Acting Designated Senior Official for Information Resources Management.
[FR Doc. 97-15273 Filed 6-10-97; 8:45 am]
BILLING CODE 7590-01-P